Aligos Therapeutics (ALGS) Return on Assets (2020 - 2026)

Aligos Therapeutics has reported Return on Assets for 7 years, with the latest figure at 0.01% in Q1 2026.

• For the quarter ending Q1 2026, Return on Assets fell 1.0% year-over-year to 0.01%; the trailing twelve-month figure through Mar 2026 stood at 0.01% (down 1.0% YoY), and the FY2025 full-year result was 0.0%, up 1.0% from the prior year.
• Return on Assets for Q1 2026 stood at 0.01%, down from 0.0% in the prior quarter.
• The five-year high for Return on Assets was 0.0% in Q4 2025, with the low at 0.02% in Q4 2024.
• Historically, Return on Assets has averaged 0.01% across 5 years, with a median of 0.01% in 2022.
• Annual changes were most pronounced in 2024 — Return on Assets slipped 1 bps — and 2025, when it gained 1 bps.
• Aligos Therapeutics' Return on Assets stood at 0.01% in 2022, then decreased by 20 bps to 0.01% in 2023, then plunged by 124 bps to 0.02% in 2024, then soared by 85 bps to 0.0% in 2025, then plunged by 384 bps to 0.01% in 2026.
• The last three Return on Assets figures came in at 0.01% (Q1 2026), 0.0% (Q4 2025), and 0.01% (Q3 2025), per Business Quant data.